| T |
2026-06-16 08:28 |
2026-06-11 |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Kalif Eliyahu Sharon |
EVP, CFO |
S - Sale |
$34.10 |
-106.6K |
65.6K |
-62% |
-$3.63M |
| T |
2026-05-18 16:00 |
2026-05-14 |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Kalif Eliyahu Sharon |
EVP, CFO |
S - Sale |
$35.61 |
-153.3K |
172.2K |
-47% |
-$5.46M |
| D |
2026-03-09 |
2026-03-05 |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Kalif Eliyahu Sharon |
EVP, CFO |
M - OptEx |
— |
+19.9K |
325.4K |
+7% |
— |
| DM |
2026-03-06 |
2026-03-04 |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Kalif Eliyahu Sharon |
EVP, CFO |
M - OptEx |
— |
+56.8K |
282.3K |
+25% |
— |
| DM |
2026-03-05 |
2026-03-03 |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Kalif Eliyahu Sharon |
EVP, CFO |
M - OptEx |
— |
+191.3K |
107.3K |
New |
— |
| T |
2026-03-02 |
2026-02-26 |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Kalif Eliyahu Sharon |
EVP, CFO |
S - Sale |
$33.64 |
-345.8K |
57.5K |
-86% |
-$11.63M |
| T |
2025-06-16 |
2025-06-12 |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Kalif Eliyahu Sharon |
EVP, CFO |
S - Sale |
$17.08 |
-55.8K |
403.3K |
-12% |
-$952.6K |
| D |
2025-03-07 |
2025-03-05 |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Kalif Eliyahu Sharon |
EVP, CFO |
M - OptEx |
— |
+21.4K |
459.1K |
+5% |
— |
| DM |
2025-03-06 |
2025-03-04 |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Kalif Eliyahu Sharon |
EVP, CFO |
M - OptEx |
— |
+239.9K |
231.3K |
New |
— |
| DT |
2025-03-04 |
2025-02-28 |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Kalif Eliyahu Sharon |
EVP, CFO |
S - Sale+OE |
$16.21 |
-55.8K |
147.9K |
-27% |
-$903.7K |
| DT |
2025-03-04 |
2025-03-03 |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Kalif Eliyahu Sharon |
EVP, CFO |
M - OptEx |
— |
+49.8K |
197.7K |
+34% |
— |
| DMT |
2024-03-07 |
2024-03-05 |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Kalif Eliyahu Sharon |
EVP, CFO |
M - OptEx |
— |
+73.7K |
259.9K |
+40% |
— |
| DT |
2024-03-07 |
2024-03-06 |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Kalif Eliyahu Sharon |
EVP, CFO |
S - Sale+OE |
$13.52 |
-77.5K |
203.7K |
-28% |
-$1.05M |
| DM |
2024-03-05 |
2024-03-03+ |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Kalif Eliyahu Sharon |
EVP, CFO |
M - OptEx |
— |
+83.3K |
207.5K |
+67% |
— |
| D |
2024-03-01 |
2024-02-28 |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Kalif Eliyahu Sharon |
EVP, CFO |
M - OptEx |
— |
+18.4K |
124.2K |
+17% |
— |
| D |
2024-02-15 |
2024-02-13 |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Kalif Eliyahu Sharon |
EVP, CFO |
M - OptEx |
— |
+6,630 |
105.8K |
+7% |
— |
|
2023-08-09 |
2023-08-07 |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Kalif Eliyahu Sharon |
EVP, CFO |
S - Sale |
$9.73 |
-35.1K |
99.2K |
-26% |
-$341.8K |
| DM |
2023-03-07 |
2023-03-04+ |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Kalif Eliyahu Sharon |
EVP, CFO |
M - OptEx |
— |
+54.9K |
134.3K |
+69% |
— |
| DM |
2023-03-02 |
2023-02-28 |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Kalif Eliyahu Sharon |
EVP, CFO |
M - OptEx |
— |
+63.4K |
79.4K |
+396% |
— |
| D |
2023-02-15 |
2023-02-13 |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Kalif Eliyahu Sharon |
EVP, CFO |
M - OptEx |
— |
+6,629 |
16.0K |
+71% |
— |
|
2022-08-24 |
2022-08-22 |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Kalif Eliyahu Sharon |
EVP, CFO |
S - Sale |
$10.07 |
-55.5K |
9,376 |
-86% |
-$558.9K |
| D |
2022-03-08 |
2022-03-05 |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Kalif Eliyahu Sharon |
EVP, CFO |
M - OptEx |
— |
+21.4K |
64.9K |
+49% |
— |
| D |
2022-03-02 |
2022-02-28 |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Kalif Eliyahu Sharon |
EVP, CFO |
M - OptEx |
— |
+18.4K |
43.5K |
+74% |
— |
| D |
2022-02-15 |
2022-02-13 |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Kalif Eliyahu Sharon |
EVP, CFO |
M - OptEx |
— |
+6,629 |
25.1K |
+36% |
— |